Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Malignant pleural mesothelioma (MPM) is a highly lethal form of pleural cancer
characterized by a scarcity of effective therapeutic interventions, resulting in unfavorable …

Abstract A new World Health Organization (WHO) Classification of Tumors of the Pleura has
recently been published. While the histologic classification of pleural malignant …

The diagnosis of malignant mesothelioma in effusion cytology specimens is controversial.
BAP1 immunohistochemistry and p16 fluorescence in situ hybridization (FISH) have recently …

Objective: To provide practical guidelines for the cytopathologic diagnosis of malignant
mesothelioma. Data Sources: Cytopathologists with an interest in the field involved in the …

Abstract Malignant Pleural Mesothelioma (MPM) remains a relevant public health issue, and
asbestos exposure is the most relevant risk factor. The incidence has considerably and …

Malignant pleural mesothelioma (MPM), an asbestos-induced tumor, represents significant
diagnostic challenges for pathologists. Its histological diagnosis is stepwise and should be …

Malignant pleural mesothelioma (MPM) is a malignant tumor originating from the pleura, and
its incidence has been increasing in recent years. Due to the insidious onset and strong …

Malignant pleural mesothelioma (MPM) is a rare and aggressive tumor with a variable
incidence among different countries. Occupational asbestos exposure is the most important …

Advanced malignancy is a prevalent cause of exudative pleural effusion. The management
of malignant pleural effusion (MPE) has been the subject of several recent randomized …